The Pharma Letter (or TPL), is an English pharmaceutical,

generics Generic or generics may refer to: In business * Generic term, a common name used for a range or class of similar things not protected by trademark * Generic brand, a brand for a product that does not have an associated brand or trademark, other ...

and

biotechnology Biotechnology is the integration of natural sciences and engineering sciences in order to achieve the application of organisms, cells, parts thereof and molecular analogues for products and services. The term ''biotechnology'' was first used b ...

news and analysis service.

Description

Coverage includes: * Company news. Financial reports, marketing developments, trends and strategies, corporate development, company profiles, legal influences,

Research and Development Research and development (R&D or R+D), known in Europe as research and technological development (RTD), is the set of innovative activities undertaken by corporations or governments in developing new services or products, and improving existi ...

trends,

mergers and acquisitions Mergers and acquisitions (M&A) are business transactions in which the ownership of companies, other business organizations, or their operating units are transferred to or consolidated with another company or business organization. As an aspect ...

activity, sales performance,

stock market A stock market, equity market, or share market is the aggregation of buyers and sellers of stocks (also called shares), which represent ownership claims on businesses; these may include ''securities'' listed on a public stock exchange, as ...

analyses and personnel appointments. * Product news. Drug submissions, approvals and rejections, licensing arrangements,

clinical trial Clinical trials are prospective biomedical or behavioral research studies on human participants designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietar ...

developments and results, product development and new product introductions. * European, USA, and World news. Regulatory developments, FDA/EMEA news, market legislation, pharma market movements, reviews of current and proposed legislation and regulation, conference details, and write-ups. Barbara Obstoj is the Managing Editor, which in 2009 acquired the archives of The Pharma Marketletter, a publication Barbara owned since 1991 and prior to that edited when it was part of IMS Health. She was also the founding editor of Scrip World Pharmaceutical News from 1972 to 1976.

References

External links

The Pharma Letter
{{DEFAULTSORT:Pharma Letter Pharmacology literature News websites